Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ting Ma

Showing results (1001-1010 of 1,047) with videos related to

Pageof 105
Sort By:
Medcomm|October 13, 2025
Efficacy, Safety, and Biomarkers of Neoadjuvant Dalpiciclib (CDK4/6 inhibitor) plus Aromatase Inhibitors in Operable HER2-Negative Luminal B Breast Cancer: A Prospective, Single-Center, Single-Arm, Phase II Trial (DANCER)Yunxiang Zhou, Zhiyun Zhang, Huihui Chen, et al.
Liver Cancer|May 27, 2026
An International Phase 4 Study of Lenvatinib and Sorafenib in Real-World Patients with Unresectable Hepatocellular Carcinoma: Final AnalysisMarkus Peck-Radosavljevic, Akhmed Abdelgafur, Alessandro Granito, et al.
Nature Communications|July 21, 2019
Boosting NAD<sup>+</sup> with a small molecule that activates NAMPTStephen J Gardell, Meghan Hopf, Asima Khan, et al.
The Lancet. Infectious Diseases|May 1, 2020
Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort studyQifang Bi, Yongsheng Wu, Shujiang Mei, et al.
Innovation in Aging|November 11, 2025
Sex- and age-specific multimorbidity networks in middle-aged inpatients: a network-based comparative study between China and the United KingdomYining Bao, Hanting Liu, Qianhui Lu, et al.
Frontiers in Allergy|May 27, 2026
Pollen-induced allergic rhinitis in the central region of Inner Mongolia, China: prevalence, risk factors, and regional characteristicsTing-Ting Ma, Mei-Rong Yang, Zi-Lu Cheng, et al.
Biorxiv : the Preprint Server for Biology|January 27, 2025
LARP6 regulates the mRNA translation of fibrogenic genes in liver fibrosisHyun Young Kim, Orel Mizrahi, Wonseok Lee, et al.
ACS Combinatorial Science|February 27, 2015
Design of high-throughput screening assays and identification of a SUMO1-specific small molecule chemotype targeting the SUMO-interacting motif-binding surfaceAileen Y Alontaga, Yifei Li, Chih-Hong Chen, et al.
Cancers|September 13, 2025
UK Real-World Evidence of Using Durvalumab Plus Cisplatin and Gemcitabine in Advanced Biliary Tract Cancer via an Early Access SchemeHarry Daniels, Mona Hassan, Omer Babiker, et al.
The Lancet. Gastroenterology & Hepatology|June 27, 2017
Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trialTim Meyer, Richard Fox, Yuk Ting Ma, et al.
Pageof 105

Showing results (1001-1010 of 1,047) with videos related to

Sort By:
Pageof 105
Medcomm|October 13, 2025
Efficacy, Safety, and Biomarkers of Neoadjuvant Dalpiciclib (CDK4/6 inhibitor) plus Aromatase Inhibitors in Operable HER2-Negative Luminal B Breast Cancer: A Prospective, Single-Center, Single-Arm, Phase II Trial (DANCER)Yunxiang Zhou, Zhiyun Zhang, Huihui Chen, et al.
Liver Cancer|May 27, 2026
An International Phase 4 Study of Lenvatinib and Sorafenib in Real-World Patients with Unresectable Hepatocellular Carcinoma: Final AnalysisMarkus Peck-Radosavljevic, Akhmed Abdelgafur, Alessandro Granito, et al.
Nature Communications|July 21, 2019
Boosting NAD<sup>+</sup> with a small molecule that activates NAMPTStephen J Gardell, Meghan Hopf, Asima Khan, et al.
The Lancet. Infectious Diseases|May 1, 2020
Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort studyQifang Bi, Yongsheng Wu, Shujiang Mei, et al.
Innovation in Aging|November 11, 2025
Sex- and age-specific multimorbidity networks in middle-aged inpatients: a network-based comparative study between China and the United KingdomYining Bao, Hanting Liu, Qianhui Lu, et al.
Frontiers in Allergy|May 27, 2026
Pollen-induced allergic rhinitis in the central region of Inner Mongolia, China: prevalence, risk factors, and regional characteristicsTing-Ting Ma, Mei-Rong Yang, Zi-Lu Cheng, et al.
Biorxiv : the Preprint Server for Biology|January 27, 2025
LARP6 regulates the mRNA translation of fibrogenic genes in liver fibrosisHyun Young Kim, Orel Mizrahi, Wonseok Lee, et al.
ACS Combinatorial Science|February 27, 2015
Design of high-throughput screening assays and identification of a SUMO1-specific small molecule chemotype targeting the SUMO-interacting motif-binding surfaceAileen Y Alontaga, Yifei Li, Chih-Hong Chen, et al.
Cancers|September 13, 2025
UK Real-World Evidence of Using Durvalumab Plus Cisplatin and Gemcitabine in Advanced Biliary Tract Cancer via an Early Access SchemeHarry Daniels, Mona Hassan, Omer Babiker, et al.
The Lancet. Gastroenterology & Hepatology|June 27, 2017
Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trialTim Meyer, Richard Fox, Yuk Ting Ma, et al.
Pageof 105